In summary, these data suggest that USP7 is a tumor promoter and can serve as a therapeutic target for melanoma, potentially as a novel therapeutic strategy to respond to the resistance of advanced melanoma to chemotherapy. The gene discussed is USP7; the disease is melanoma.